BROOKS STEVEN SCOTT enters MARIZYME, INC. with 20K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/22/2020ACC: 0001493152-20-024117
Officer· Chief Medical Officer
Since Jul 2020
20K
Baseline shares
100% direct
20K
Direct ownership
1 position
40K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned20K
Total
20K direct20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Direct |
| Total | 20K | 20K direct |
Derivative Holdings1
Options
DirectUnderlying security
Common Stock
Underlying shares
40K
Shares owned
N/A
Exercise price
1.25
Expiration
—
Exercise window
—
Total
Underlying
40K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Common Stock | 1.25 | — | — | 40K | N/A |
| Total | 40K | 0.00 | ||||